stemCARE
stemCARE offers the creation, bioproduction and cryopreservation of cellular models for genetic diseases based on human pluripotent stem cells and their progenies. It supports users in the study of molecular and functional disorders associated with these diseases thanks to high-throughput sequencing technologies and advanced analytical platforms.
In addition, stemCARE assists in the search for potential pharmacological compounds by screening repositionable molecules or new chemical entities in partnership with collection owners.
The platform also offers training in cell culture techniques, quality control and autonomous use of equipment.
Labels
GenoTher (2025) | GIS IBISA (2024) | Génopole (2022) |
![]() |
![]() |
![]() |
Contact : abenchoua[AT]istem.fr
Team members
BioProduction
( Learn more … )
Cell Biology
( Learn more … )
Genome editing
( Learn more … )
High-throughput sequencing
( Learn more … )
High-throughput screening
( Learn more … )
Cell Imaging
( Learn more … )
Publications
High-throughput screening identifies bazedoxifene as a potential therapeutic for dysferlin-deficient limb girdle muscular dystrophy.
01 July 2025
British journal of pharmacology
Inhibition of poly(ADP-Ribosyl)ation reduced vascular smooth muscle cells loss and improves aortic disease in a mouse model of human accelerated aging syndrome.
02 October 2024
Cell death & disease
Pharmacological modulation of developmental and synaptic phenotypes in human SHANK3 deficient stem cell-derived neuronal models.
10 June 2024
Translational psychiatry